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Edite by Jesus AvilaAbstract Restricting transgene expression to speciﬁc cell types
and maintaining long-term expression are major goals for gene
therapy. Previously, we cloned brain-speciﬁc angiogenesis inhib-
itor 1-associated protein 4 (BAI1-AP4), a novel brain-speciﬁc
protein that interacts with BAI1, and found that it was
developmentally upregulated in the adult brain. In this report,
we isolated 5 kb of the 50 upstream sequence of the mouse BAI1-
AP4 gene and analyzed its promoter activity. Functional
analyses demonstrated that an Sp1 site was the enhancer, and
the region containing the transcription initiation site and an
AP2-binding site was the basal promoter. We examined the
ability of the BAI1-AP4 promoter to drive adult brain-speciﬁc
expression by using it to drive lacZ expression in transgenic
(TG) mice. Northern blot analyses showed a unique pattern of b-
galactosidase expression in TG brain, peaking at 1 month after
birth, like endogenous BAI1-AP4. Histological analyses dem-
onstrated the same localization and developmental expression of
b-galactosidase and BAI1-AP4 in most neurons of the cerebral
cortex and hippocampus. Our data indicate that TG mice
carrying the BAI1-AP4 promoter could be a valuable model
system for region-speciﬁc brain diseases.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The use of cell-type-speciﬁc promoters is invaluable for
generating transgenic (TG) mouse models of human diseases
and for testing the eﬀects of overexpressed functional gene
products [1]. Spatiotemporally restricted gene targeting is
needed for analyzing the functions of various molecules in a* Corresponding author. Fax: +82-62-232-6974.
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Abbreviations: BAI1-AP4, brain-speciﬁc angiogenesis inhibitor 1-
associated protein 4; HSV-TK, herpes simplex virus-thymidine kinase;
NSE, neuron-speciﬁc enolase; TG, transgenic
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is developmentally expressed in the brain, with expression in
mature neurons and paraneurons [2]. The NSE promoter has
been used to generate TG mouse models for brain-speciﬁc
disease. In TG mice expressing b-galactosidase under NSE
promoter control, the expression of the NSE-lacZ transgene
paralleled the expression of the NSE gene with regard to de-
velopmental onset, but not postnatal mRNA accumulation [3].
Previously, brain-speciﬁc angiogenesis inhibitor 1-associated
protein 4 (BAI1-AP4) was isolated as a novel brain-speciﬁc
protein that interacted with the Refsum disease gene product
and BAI1 [4,5]. In situ hybridization analyses of the brain
showed speciﬁc localization of BAI1-AP4 to the supragranular
layer in the cerebral cortex, hippocampus, dentate gyrus (DG),
Purkinje cell layer, and neuronal layers of the retina. The ex-
pression level of BAI1-AP4 increased as the development of
the brain progressed. Speciﬁcally, BAI1-AP4 expression was
markedly induced after eyelid opening, reached its highest level
at 1 month of age, and maintained a high level throughout
adult life [6]. BAI1-AP4 showed a unique pattern of spatial
expression, being expressed only in certain mature neurons in
the adult brain. However, the mechanisms regulating the
BAI1-AP4 gene at the promoter level have not yet been
reported.
In the present study, we cloned and characterized the BAI1-
AP4 gene promoter, and examined the potential of this up-
stream sequence in producing neuron-speciﬁc expression of a
heterologous protein (lacZ) in TG mice. We found that the
spatial and temporal expression patterns of the lacZ transgene
in the cerebral cortex and hippocampus of the TG brain were
roughly the same as those of endogenous BAI1-AP4. This TG
strategy using the BAI1-AP4 promoter may help in the de-
velopment of valuable animal brain-speciﬁc disease models to
study memory and learning disorders.2. Materials and methods
The investigation conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996). The Ethics Committee
of Chonnam National University Medical School approved all
experimental protocols.ation of European Biochemical Societies.
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To clone the BAI1-AP4 promoter, a 129-cell genomic library was
screened with the 50 portion of BAI1-AP4 cDNA (450 bp). One po-
sitive plaque was obtained from this screening, and genomic DNA
(11 kb) was puriﬁed and sequenced using the dideoxy chain termi-
nating approach (Fig. 1) as described [5].
2.2. Primer extension
A primer, complementary to nucleotides +28 to +55 of the BAI1-AP4
promoter, was labeled with [c-32P]ATP in the presence of T4 polynu-
cleotide kinase. The duplexes were incubated at 42 C for 1 h in the same
buﬀer plus 10 mM dNTP and 50 U of M-MLV reverse transcriptase
(Boehringer–Mannheim). The reaction products were resolved on an 8%
denaturing polyacrylamide gel followed by image analysis.
2.3. Preparation of plasmids for deletion mutants
A 3150-bp fragment containing the 50 ﬂanking region and tran-
scription start site of the BAI1-AP4 gene was prepared. PCR wasFig. 1. Partial nucleotide sequence of the BAI1-AP4 promoter. The transcrip
site is numbered +1. Nucleotide numbers are based on transcription initiatio
(Sp1, Y-box, CTF/NF-1, and AP-2) are boxed. The putative repressor factoused to prepare deletion constructs, with genomic DNA of BAI1-AP4
as template. PCR was performed using speciﬁc primers with KpnI and
SmaI linker sites. Each PCR product was cloned into the pGL3-Basic
vector (Promega) at the KpnI and SmaI sites. The pGL3-Basic plas-
mids containing various segments of the 50 ﬂanking region of the
BAI1-AP4 gene were puriﬁed by CsCl ultracentrifugation. The re-
sulting plasmids in pGL3-Basic contained various segments of the 50
region of the BAI1-AP4 gene, including a transcription initiation site
(Fig. 2). Plasmids were designated pBAP4-3126, pBAP4-3032,
pBAP4-839, pBAP4-741, pBAP4-492, pBAP4-356, pBAP4-276,
pBAP4-224, pBAP4-3126 (del )151/+260), pBAP4-224 (del +66/
+260), pBAP4-224 (del )11/+260), pBAP4-224 (del )46/+260) and
pBAP4-224 (del )91/+260); the plasmids contained BAI1-AP4 nu-
cleotide residues )3126 to +260, )3032 to +260, )839 to +260, )741
to +260, )492 to +260, )356 to +260, )276 to +260, )224 to +260,
)3126 to )151, )224 to +66, )224 to )11, )224 to )46 and )224
to )91, respectively (Fig. 2). All constructs were conﬁrmed by
sequencing.tion initiation site is boxed and the beginning of the transcription start
n at +1. The consensus sequences of the nuclear protein-binding sites
r-binding site is underlined.
Fig. 2. The location of the binding sites for transcription factors and the transcriptional activities of various deletion constructs of the BAI1-AP4
promoter. Deletion constructs of the BAI1-AP4 promoter were fused to the luciferase reporter gene and transfected into 293HEK cells. After in-
cubation, the cells were assayed for luciferase activity. (A) The luciferase activity of the constructs containing all elements (pBAP4-3126) was taken as
100% and the luciferase activity of each construct is expressed as a relative percentage. (B) The luciferase activity of the pBAP4-224 was counted as
100% and the luciferase activity of each construct is expressed as a relative percentage.
M.-Y. Kim et al. / FEBS Letters 566 (2004) 87–94 892.4. Construction of a BAI1-AP4-lacZ fusion
To generate the BAI1-AP4 promoter-lacZ transgene, a NotI–NotI
restriction fragment carrying 3475 bp of lacZ cDNA from the pCMVb
vector was cloned into the pUCBM20 vector. A XhoI–NotI restriction
fragment of approximately 9.0 kb was subcloned directly upstream of
the lacZ cDNA. This fragment contained 5033 bp of 50 ﬂanking se-
quence and 276 bp of BAI1-AP4 (encompassing exons 1–2, up to but
not including the initiation codon) and 4.0 kb of intron 1 (Fig. 3A).
The SV40 early region transcription termination/polyadenylation site
was inserted downstream from the lacZ cDNA insert.
2.5. Luciferase assays
Human embryonic kidney (293HEK) cells were grown in DMEM
supplemented with 10% heat-inactivated FBS at 37 C in 5% CO2
incubator. Transfection of each plasmid DNA (2 lg) into 293HEK
cells was performed with the non-liposomal lipid FuGENE 6 (Boeh-
ringer–Mannheim) following the manufacturer’s protocol. The cells
were cultured at 37 C in 5% CO2 for 36 h. For luciferase assays, cells
were harvested, pelleted at 14,000 rpm, washed in cold phosphate-
buﬀered saline (PBS), resuspended in lysis buﬀer, and incubated at
room temperature for 20 min. Cell debris were removed at 14,000 rpm
(4 C) and the supernatant was collected in a new tube. Luciferase
activity was measured via luminometer, for 50 s at 25 C immediately
following the automatic injection of substrate. The proteins of mouse
tissues were prepared as described [4].
2.6. Generation and maintenance of TG mice
FVB/N6 mice (Dae Han Laboratory Animal Research Center,
Korea) were used as donors and recipients for the generation of TG
mice. To generate the BAI1-AP4 promoter-lacZ transgene, a 13-kbfragment composed of the BAI1-AP4 promoter, lacZ cDNA, and
SV40 polyadenylation sequences was puriﬁed by agarose gel electro-
phoresis followed by Qiaquick Gel Extraction Kit (Qiagen). This
fragment was used for pronuclear injection of FVB/N6 oocytes [7].
Injected eggs were transferred to pseudopregnant FVB females using
standard techniques [8]. Heterozygous TG progenies (F1) were ob-
tained by breeding the founders (F0) to FVB/N6 wild-type mice. The
F1 male and female littermates were bred back to FVB/N6 wild-type
mice to produce F2 progenies, and the positive F2 generations were
used for the studies. TG mice carrying the lacZ gene were identiﬁed
by PCR ampliﬁcation of tail genomic DNA using primers
50-ATCCCCACAGGAGCCAAACCAGAG-30 (sense) and 50-TCTT-
CGCTATTACGCCAG-30 (antisense), which amplify a 280-bp frag-
ment spanning the junction between the BAI1-AP4 promoter and the
lacZ gene. Three lacZ TG founders were produced.2.7. Northern blot analyses
To isolate total RNA, various mouse tissues were homogenized with
a polytron homogenizer in 4.0 M guanidine thiocyanate and 1% b-
mercaptoethanol. The RNA was puriﬁed by centrifugation through 5.7
M CsCl as described [4]. RNA samples were quantitated by spectro-
photometry at 260 nm. For Northern blot analysis, total RNA (10
lmg) was denatured with glyoxal, separated by size on 1.0% agarose
gels, and transferred to Genescreen (DuPont). The probes used were a
1250-bp NotI–EcoRV fragment (50 portion) derived from the lacZ
cDNA and a part of BAI1-AP4 cDNA (nucleotide residues 1–415).
Probes were radiolabeled by nick translation and hybridizations and
signal visualizations were performed as described [4]. The integrity of
the RNA samples was established by Northern blot analysis with a
mouse GAPDH or b-actin probe.
Fig. 3. Structure of the BAI1-AP4-lacZ transgene constructs and Northern blot assay of b-galactosidase and BAI1-AP4 expression in TG mouse
tissues. (A) The BAI1-AP4-lacZ transgene consists of the entire coding sequence of the mouse lacZ cDNA (3475 bp) cloned downstream of the 9-kb
BAI1-AP4 promoter. The SV40 early region transcription terminator and polyadenylation site were inserted downstream from the lacZ cDNA. The
transcription factor-binding sites [Sp1, AP-2, and a putative transcription factor (PTF)], considered to be important to the expression pattern, are
circled. (B) Total RNAs isolated from various tissues of adult TG mice were hybridized with a b-galactosidase cDNA probe. (C) The same blot was
rehybridized with a BAI1-AP4 cDNA probe. (D) For each blot, RNA ﬁdelity was conﬁrmed by rehybridization with a b-actin probe.
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Mice were anesthetized with an intraperitoneal injection of sodium
pentobarbital (50 mg/kg) and the brain was ﬁxed by in vivo perfusion
of the abdominal aorta with 4% paraformaldehyde in PBS for 10 min.
The brain was excised and then immersed in the same ﬁxative for 3 h at
4 C. The blocks were washed in PBS, dehydrated in a graded series of
ethanol washes, and embedded in paraﬃn. Tissue sections (6 lm) were
mounted on gelatin-coated glass slides. Sense and antisense cRNA
probes speciﬁc for the mouse BAI1-AP4 were generated from the re-
combinant molecules (nucleotide residues 1–415) using T3 and T7
RNA polymerases in the presence of digoxigenin-11-UTP (Boehrin-
ger–Mannheim). These probes were also used as c-DNA probes in the
Northern blot analysis. In situ hybridization was performed as de-
scribed previously [4].2.9. b-Galactosidase staining and immunohistochemistry of TG brain
TG brain tissue was stained as whole mounts using a b-galactosidase
staining kit (Specialty Media) as follows. The ﬁxed brain was washed
with PBS at 4 C. Staining was carried out at 37 C for 16 h in a so-
lution of 5-bromo-4-chloro-3-indolyl-b-galactoside (X-gal) at a ﬁnal
concentration of 0.4 mg/ml with 4 mM K3Fe(CN)6, 4 mM
K4Fe(CN)6  6H2O, and 2 mM MgCl2 in PBS. After staining, coronal
or horizontal sections of TG brain tissue were rinsed with PBS and
photographed as whole mounts. These samples were then embedded in
paraﬃn, cut at 50 lm, de-paraﬃnized, counterstained with neutral red
(0.5%), and photographed.
Immunohistochemistry was performed using an immunoperoxidase
procedure (VECTA ABC Kit, VECTOR Lab). The X-gal-stained
brain tissue sections (50 lm) were treated with 3% H2O2 in 60%
methanol for 15 min to quench endogenous peroxidase activity. After
washing, the sections were blocked in PBS containing 5% normal horse
serum for 1 h. The sections were incubated for 12–14 h with the
monoclonal antibody for neuronal nuclei (NeuN, Chemicon) diluted in
PBS with 0.3% bovine serum albumin. The sections were then rinsed,
incubated sequentially for 30 min each with the biotinylated secondary
antibody and the ABC reagents, followed by a 5-min incubation with
the DAB, and photographed on a light microscope.3. Results and discussion
3.1. Nucleotide sequence of the BAI1-AP4 promoter
We sequenced the BAI1-AP4 gene promoter from residue
)1044 and identiﬁed the location of several putative tran-
scription factor-binding sites (Fig. 1). There were several
consensus nuclear protein-binding sites; one inverted Sp1-
binding site, a Y-box-binding site, a CTF/NF1-binding site,
one AP2-binding site, and a putative repressor factor-binding
site. The transcription initiation site was identiﬁed by primer
extension analysis with mouse brain mRNA as a template.
There was no TATA box motif.
3.2. Transcriptional activity of the BAI1-AP4 promoter gene
Our previous report showed a unique developmental pattern
of strong BAI1-AP4 expression in the adult brain, but weak
ubiquitous expression of BAI1-AP4 was observed in all em-
bryonic tissues examined [4]. In this study, we used embryonic
293HEK cells, because they have the transcription factors
corresponding to those observed in the BAI1-AP4 promoter
and also have good transfection eﬃciency. To elucidate the
role of each element, several fragments of the promoter were
prepared and the transcriptional activities of these constructs
were determined by luciferase assay after transfection into
293HEK cells.
The promoter activity of the construct pBAP4-3126 was
much higher than that of pBAP4-3022 and the activity of
pBAP4-839 was much higher than that of pBAP4-741
(Fig. 2A). These ﬁndings suggest that the regions containing
the Sp1-binding site and the inverted Sp1-binding site are the
major enhancers of promoter activity. Sp1 is a ubiquitous
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including housekeeping genes, signal pathway-induced genes,
and tissue-speciﬁc genes [9,10]. However, there were no dif-
ferences in the promoter activities among pBAP4-741, pBAP4-
492, and pBAP4-356, indicating that the Y-box-binding site
and the CTF/NF1-binding site did not aﬀect reporter expres-
sion in these cells.
In contrast, the promoter activity of the construct pBAP4-
276 was much lower than that of the pBAP4-224, indicating
that residues )276 to )25 might contain a putative repressor-
binding site (Fig. 1). A putative transcription factor, though it
is not yet identiﬁed or cloned, may bind to this element in a
manner similar to the RE1-silencing transcription factor,
which helps restrict neuronal traits to neurons by blocking
expression in non-neuronal cells [11,12].
The region in the pBAP4-224 construct containing the AP2-
binding site and the transcription initiation site has potent
transcriptional activity (Fig. 2B). The construct without this
region [namely pBAP4-3126 (del )151/+260)] exhibited almost
no transcriptional activity. The activities of the constructs
without the AP2-binding site and/or the transcription initia-
tion site [namely pBAP4-224 (del +66/+260), pBAP4-224 (del
)11/+260), pBAP4-224 (del )46/+260), and pBAP4-224 (del
)91/+260)] were markedly decreased. These ﬁndings indicate
that the region containing the transcription initiation site and
the AP2-binding site is the basal promoter for the expression
of the BAI1-AP4 gene. The AP-2 transcription factor is be-
lieved to play a crucial role in the control of gene expression in
response to cell diﬀerentiation signals within neural crest and
epidermal cell lineages, and it is reported to be a critical reg-
ulatory molecule required for vertebrate development [13]. AP-
2 is also a developmentally regulated transcription factor
expressed in ectodermal cell lineages and essential for neural
tube morphogenesis, and constitutively regulates several genes
that have fundamental roles during development.
In the NSE promoter, the important upstream sequences are
the cAMP response element and the AP-1-, AP-2-, and Sp1-
binding sequences. In intron 1 of NSE gene, a cAMP response
element, E2F-binding sequence, early growth response-1-
binding motif, and a neuron-speciﬁc element-like sequence
were found [14]. These ﬁndings suggested that the neuron-
speciﬁc enhancement of NSE-CAT reporter expression is
regulated by the combination of the eﬀects of the 50 upstream
region and intron 1 of the NSE gene. Taken together, we hy-
pothesize that AP-2 is important to the BAI1-AP4 promoter
for developmentally regulated expression, whereas the ex-
pression of BAI1-AP4 gene is restricted to neurons by some
other putative transcription factor. The cloning and charac-
terization of this repressor is under investigation.
3.3. Expression of the BAI1-AP4-lacZ fusion gene and creation
of TG mice expressing b-galactosidase in the brain
The BAI1-AP4 promoter was fused to lacZ (Fig. 3A). To
test whether the BAI1-AP4 promoter-lacZ fusion gene is
functional in eukaryotic cells, this transgene construct was
transfected into HEK293 embryonic kidney cells. These cells
were chosen because the BAI1-AP4 gene was ubiquitously
expressed at a low level in embryonic tissues. Enzymatically
active b-galactosidase was expressed in transfected 293 cells, as
determined by the X-gal staining of cells (data not shown).
Thus, the BAI1-AP4 promoter-transgene construct does
function in these cells.To ascertain whether the BAI1-AP4 promoter would spe-
ciﬁcally drive lacZ reporter gene expression in the brain, TG
mice were generated using a 13-kb gene fragment that con-
tains the BAI1-AP4 promoter, lacZ cDNA, and SV40 poly-
adenylation sequences. TG mice were identiﬁed by PCR
ampliﬁcation of tail genomic DNA with primers that amplify a
280-bp region spanning the junction between the BAI1-AP4
promoter and the lacZ cDNA (data not shown). Three BAI1-
AP4/lacZ TG founders were produced and these founder mice
gave rise to oﬀspring in crosses with wild-type FVB mice. The
PCR analysis of the progeny showed that the lacZ TG DNA
was inherited with constant copy numbers. All founders
transmitted the introduced BAI1-AP4-lacZ gene in a Mende-
lian fashion (about 50% heterozygotes).
3.4. Expression of the BAI1-AP4-lacZ transgene in mouse brain
To determine the extent of transgene expression, we per-
formed Northern blot analysis of various tissues from het-
erozygote oﬀspring of the three founders using a lacZ cDNA
probe. A transcript of the expected size (4.0 kb) was observed
in brain tissue of heterozygotes, but not in other tissues
(Fig. 3B). BAI1-AP4 signal was also obtained from the same
blot using a BAI1-AP4 cDNA probe (Fig. 3C). However, no
lacZ transgene transcript was detected in any tissues from non-
TG littermates (data not shown). These results indicate that
the BAI1-AP4-lacZ transgene is expressed only in the brain
and expression of the BAI1-AP4-lacZ transgene parallels the
expression pattern of BAI1-AP4.
3.5. Developmental expression of lacZ-transgene in the TG
mouse brain
The temporal regulation of lacZ-transgene expression was
analyzed by Northern blot analysis. BAI1-AP4/lacZ TG
mouse brain RNAs were isolated at sequential time points
after birth. The lacZ probe detected a very low level of the
4.0-kb transgene transcript at the 1st day after birth
(Fig. 4A). The BAI1-AP4 signal was also obtained from the
same blot using a BAI1-AP4 cDNA probe (Fig. 4B). During
neonatal development, the lacZ mRNA level gradually in-
creased, showing an expression pattern roughly similar to that
of the endogenous BAI1-AP4 mRNA. The expression level of
the lacZ transgene and BAI1-AP4 mRNAs appeared to in-
crease as the development of the brain progressed, and reached
their highest levels 4 weeks after birth. The lacZ transgene
expression decreased slightly after 1 month and this level was
maintained through adult life (Fig. 4A). No lacZ transgene
transcript was detected in brain from non-TG littermates at
any age (data not shown). These results indicate that the ex-
pression level of lacZ appeared to increase as the development
of the brain progressed, and BAI1-AP4 and b-galactosidase
expression overlap in the developing nervous system.
The developmental time course ofNSE expression in the brain
is very similar to that ofBAI1-AP4gene, both showing gradually
increased expression from birth to adulthood. However, when
we compared the b-galactosidase reporter gene expression in the
brain between TG mice under NSE and BAI1-AP4 promoters,
we found some diﬀerences. In the NSE/lacZ TG mouse brain,
expression of the NSE-lacZ transgene did not parallel the NSE
gene with regard to postnatal mRNA accumulation [3]. The
endogenous NSE mRNA level increased considerably during
the postnatal period, while the NSE/lacZ mRNA remained at
the neonatal level. Moreover, lacZ mRNA was already ex-
Fig. 4. The developmental pattern of b-galactosidase and BAI1-AP4
expression in the BAI1-AP4/lacZ TG mouse brain. (A) Total brain
RNAs were isolated at various stages of mouse development and hy-
bridized with a b-galactosidase cDNA probe. (B) The same blot was
rehybridized with a BAI1-AP4 cDNA probe. (C) RNA ﬁdelity was
conﬁrmed by rehybridization with a GAPDH probe. N-Ad, normal
adult brain RNA from non-TG mouse; T-1d, TG brain of postnatal
day 1; T-1W, TG brain of postnatal day 7; T-2W, TG brain of post-
natal day 14; T-3W, TG brain of postnatal day 21; T-4W, TG brain of
postnatal day 28; T-5W, TG brain of postnatal day 35; T-6W, TG
brain of postnatal day 42; T-Ad, 3-month old TG adult brain.
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18.5). In contrast, BAI1-AP4/lacZwas expressed after birth, and
the expression level of both BAI1-AP4 and b-galactosidase ap-
peared to increase as the development of the brain progressed
until 4 weeks after birth. However, compared with the devel-
opmental expression of endogenous BAI1-AP4, a slightly lower
level of b-galactosidase was maintained from 4 weeks through
adulthood. It seems that the developmental reporter gene ex-
pression from the 5-kb BAI1-AP4 promoter did not perfectly
match the endogenous BAI1-AP4 gene pattern, indicating that
further extension of the 50 upstream sequence would be neces-
sary for a BAI1-AP4/lacZ construct to perfectly reproduce en-
dogenous expression. Collectively, our results indicate that the
BAI1-AP4/lacZ TG brain is more appropriate than the NSE/
lacZ TG brain to study the mechanisms by which activation of
gene expression occurs in the adult brain.Fig. 5. Histological detection of b-galactosidase and endogenous
BAI1-AP4 in neurons of several regions of the BAI1-AP4/lacZ TG
adult mouse brain. b-Galactosidase activity in coronal (A,B) and
horizontal (C) sections of TG brain tissue was examined by incubation
with X-gal. The b-galactosidase was highly expressed throughout the
whole cerebral cortex (squares; A,C), all ﬁelds of hippocampus proper
(circles; A,C), the DG (A). It was moderately expressed at the cere-
bellum (triangles; B,C), but weakly in the several nuclei of midbrain
(B). At higher magniﬁcation, entorhinal cortical sections showing
strong BAI1-AP4 hybridization signals (D) or b-galactosidase activity
(E) in neurons of layers II–III and moderate signals in layers IV–VI.
Pyramidal cells of all ﬁelds (CA1, CA2, CA3, and CA4) of Ammon’s
horn and granule cells of the DG show moderate BAI1-AP4 hybrid-
ization signals (F) or b-galactosidase activity (G). Cerebellar cortical
sections show BAI1-AP4 hybridization signals (H) or b-galactosidase
activity (I) in the molecular (M, very weak) and granular (G, moder-
ate) layers. (J) In high-power ﬁelds of cerebral cortex, b-galactosidase
was expressed in some neurons, but not all cortical neurons.
b-Galactosidase-positive neurons have pale blue perikarya with one or
two dark blue spots. (K) b-Galactosidase-expressing neurons in the
cerebral cortex were also stained with anti-neuronal nuclei antibody, a
neuron-speciﬁc marker. Scale bars D,E, 50 lm; F,G, 100 lm; H,I, 220
lm; and J,K, 25 lm.
c3.6. Localization of lacZ-transgene and neuron-speciﬁc
expression of b-galactosidase in the brain
Having established that expression of the lacZ-transgene is
targeted to the brain, the distribution of b-galactosidase ac-
tivity in the BAI1-AP4/lacZ TG mouse brain was determined
by incubation of sectioned brain tissue with X-gal. Incubation
with X-gal gave negligible background staining in brain tissue
from non-TG mice. b-Galactosidase was expressed throughout
the whole cerebral cortex (Fig. 5A), with a particularly high
level present in the supragranular layer (Fig. 5C), hippocampal
formation (Fig. 5A and C), and cerebellar cortex (Fig. 5B and
C). It was weakly expressed in the trigeminal, abducent, facial,
Fig. 6. Developmental expression of b-galactosidase in cerebral cortex
and hippocampal formation of the BAI1-AP4/lacZ TG mouse brain.
Cerebral cortex (A–C) and hippocampus (D–F) of the BAI1-AP4/lacZ
TG mouse brain were stained with X-gal at time points after birth (5th
day, 1 month, and 6 months). At day 5, a very low activity of the b-
galactosidase was detected throughout the whole cerebral cortex (A)
and hippocampus (D). At 4 weeks, the expression level of the b-ga-
lactosidase increased highly in the whole cerebral cortex (B) and hip-
pocampus (E). In adulthood (6 months), b-galactosidase activity
decreased slightly in the cerebral cortex (C), but it was maintained in
the hippocampus (F). Scale bars, 100 lm.
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stem reticular formation (Fig. 5B). These results match the
distribution of endogenous BAI1-AP4 mRNA [5]. At higher
magniﬁcation, BAI1-AP4 hybridization signals and b-galac-
tosidase activity show strong signals in neurons of layers II–III
and moderate signals in layers IV–VI of entorhinal cortical
sections (Fig. 5D and E). Strong b-galactosidase activity
(Fig. 5G) as well as BAI1-AP4 hybridization signals (Fig. 5F)
were also noted in the pyramidal cells of all ﬁelds of the hip-
pocampus proper and the granule cells of the DG. Cerebellar
cortical sections showed BAI1-AP4 hybridization signals
(Fig. 5H) or b-galactosidase activity (Fig. 5I) moderately in the
granular layer, but very weakly in the molecular layer. These
results indicated that the 5-kb BAI1-AP4 upstream sequence
could drive lacZ expression in TG brain with major distribu-
tions to the cerebral cortex and hippocampal formation that
are similar to those of endogenous BAI1-AP4.
However, endogenous BAI1-AP4 hybridization signals
(Fig. 5H) but not exogenous b-galactosidase activity (Fig. 5I)
were observed in most Purkinje cells. Thus, in contrast to ce-
rebral cortex, expressions of b-galactosidase and BAI1-AP4
were not coincident in the cerebellum. This ﬁnding indicates
that 5-kb of the BAI1-AP4 upstream sequence is still not en-
ough to perfectly reproduce the endogenous BAI1-AP4 ex-
pression pattern in the brain, and suggests again that an
additional regulatory region exists beyond this 5-kb upstream
region. Recently, it was reported that the bacterial artiﬁcial
chromosome (BAC) TG approach has several methodological
advantages, including a high rate of success in reproducing
endogenous expression patterns, because the carrying capacity
of BACs is several hundred kilobases [15]. Thus, further ex-
tending of 50 upstream sequence into present BAI1-AP4 pro-
moter-transgene construct or using BAC TG vectors is needed
to obtain perfect reproduction of the endogenous BAI1-AP4
expression pattern in the brain.
To understand the mechanisms of neuronal development,
many researchers are interested in neuron-speciﬁc promoters
and regulatory elements [16,17]. Many of the promoters that
have been examined have failed to confer spatial or temporal
speciﬁcity to the transgene [18–21]. In contrast, the promoter
elements of NF-L [22], dopamine b-hydroxylase [23], and NSE
[3] have been shown to exhibit neuron-speciﬁc targeting and
approach the temporal expression patterns of the endogenous
genes. These reports also indicated that the ﬁdelity of spatial
and temporal expression of transgenes driven by a neural-
speciﬁc promoter was dependent on the size of promoter
fragment and the site of transgene insertion. However, their
targeting sites in the brain and the onset of their peak ex-
pression are diﬀerent from that of BAI1-AP4.
Next, we determined which cell types within the nervous
system expressed b-galactosidase. In high-power views, b-ga-
lactosidase was expressed in some neurons of the cerebral
cortex. Some but not all of cortical neurons and most neurons
positive for b-galactosidase had pale blue perikarya with one
or two dark blue spots, usually found against the cell mem-
brane (Fig. 5J). This result suggests that b-galactosidase is
largely restricted to cell bodies of mature neurons. In addition,
the hybridization signal of BAI1-AP4 was almost exclusively
of neuronal origin (Fig. 5D), whereas neuroglia and neuraxis
appeared to express low to undetectable levels [5]. Also, higher
magniﬁcation of the cerebellum showed that granule cells and
neurons of the deep cerebellar nuclei were stained (Fig. 5I). Incontrast, the molecular layer showed sparse reaction, sug-
gesting low-level expression of BAI1-AP4 or b-galactosidase
(Fig. 5H and I). Glial cells in the white matter showed no re-
action (Fig. 5H and I). To conﬁrm the neural speciﬁcity of the
lacZ-transgene expression pattern, we double-stained the
BAI1-AP4/lacZ TG brain tissue with X-gal and anti-neuronal
nuclei antibody, a neuron-speciﬁc marker. b-Galactosidase-
expressed neurons in the cerebral cortex (Fig. 5K) and hip-
pocampal formation (data not shown) were also stained with
anti-neuronal nuclei antibody. These observations demon-
strated again that endogenous BAI1-AP4 and lacZ-transgene
expression were speciﬁc to mature neurons.
3.7. Developmental expression of b-galactosidase in cerebral
cortex and hippocampus
Since, in the Northern blot results, the lacZ-transgene ex-
pression from the BAI1-AP4 promoter was developmentally
regulated (Fig. 4A), we examined whether b-galactosidase was
developmentally expressed in cerebral cortex and hippocam-
pal formation of the BAI1-AP4/lacZ TG mouse brain. The
brain tissues from one litter were used at sequential time points
after birth. A very low level of the b-galactosidase was ex-
pressed throughout the whole cerebral cortex (Fig. 6A) and
94 M.-Y. Kim et al. / FEBS Letters 566 (2004) 87–94hippocampal formation (Fig. 6D) at the 5th day after birth. At
4 weeks after birth, the expression level of b-galactosidase in-
creased in the whole cerebral cortex (Fig. 6B) and hippocam-
pal formation (Fig. 6E). However, at 6 months after birth,
b-galactosidase expression decreased slightly in the cerebral
cortex (Fig. 6C), but it was maintained in the hippocampal
formation (Fig. 6F). Thus, the expression levels of b-galacto-
sidase in cerebral cortex and hippocampal formation, deter-
mined by X-gal staining during development, were just
following the lacZ-transgene mRNA expression pattern. These
results demonstrated that the lacZ-transgene expression by
BAI1-AP4 promoter was developmentally regulated in the TG
brain. Thus, spatial and temporal expression of b-galactosi-
dase was roughly the same as BAI1-AP4 in most neurons of
the cerebral cortex and hippocampal formation.
We also made a TG mouse expressing herpes simplex virus-
thymidine kinase (HSV-TK) gene under the control of the
BAI1-AP4 promoter. We observed that some mature neurons
expressing the HSV-TK transgene in the cerebral cortex and
hippocampus proper exhibited a mild degree of necrosis, such
as a shrunken cell body and pyknotic dark nucleus following
ganciclovir administration (data not shown). The functional
eﬃcacy of these morphological changes was demonstrated by
abnormal behavior, such as circling or tumbling. Thus, gen-
eration of HSV-TK TG mice shows that the BAI1-AP4 pro-
moter functionally drives transgene expression in speciﬁc brain
regions of the adult mouse.
Collectively, our present results show that the 5-kb BAI1-
AP4 upstream sequence expresses a reporter gene in TG brain
with major distributions to the cerebral cortex and hippo-
campal formation with a developmentally upregulated pattern.
Various valuable region-speciﬁc brain disease models, such as
Alzheimer’s disease, might be developed by overexpressing
pathological mutant proteins in restricted brain regions under
control of the BAI1-AP4 promoter. Moreover, this promoter
could be used for resolving the mechanisms by which activa-
tion of gene expression occurs in the adult brain.Acknowledgements: We thank Song Eun Lee for assisting immuno-
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